AzTrials
AzTrials

Loosening, ProsthesisMULTICIMANCT06924567

Radiographic Stability of Hip Prosthesis Prior to Revision Surgery

An observational study of Loosening, Prosthesis and Hip Arthropathy, run by Georgios Tsikandylakis, MD PhD at 6 sites in 3 countries.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this validation study is to compare the preoperative implant stability, assessed by Implant Movement Analysis (IMA), provocation dual CT scans, with the intraoperative stability evaluation in revision hip arthoplasty. Read more about this study

Who is it for?
Any age
Conditions the study is for
Loosening, Prosthesis, Hip Arthropathy
What is being tested?
Implant motion provocation CT
How many people
600 participants
Where
6 sitesin 3 countries
Study dates
15 Sep 2026to 31 Dec 2029
How long will I take part?
2 Months
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients with a painful total hip arthoplasty that are scheduled for revision hip arthoplasty due to suspected prosthesis loosening. At least one implant component (either cup or stem) should not have any obvious signs of loosening. Only the implant component with no obvious signs of loosening will be included in the study.

Who may be able to join

  • Patient scheduled for revision THA due to aseptic loosening.
  • One component (cup or stem) has no convincing loosening signs, based on the preoperative plain radiographs and clinical assessment by the attending surgeon.
  • Radiographs not older than 8 weeks prior to surgery.

Who cannot join

  • Both cup and stem have been preoperatively evaluated as loose
  • Instability with repeating dislocation of the THA
  • Non-aseptic revision surgery, based on preoperative work up.
  • The scheduled revisionsurgery is cancelled.

Trial locations and contacts

6 sites in 3 countries. Contact the study team or a site near you to ask about taking part.

Linda Andersson, BMA contact

0762756531

linda.mr.andersson@vgregion.se

6 sites in 3 countries

Sweden4 sites
  • Sahlgrenska University Hospital

    Gothenburg, 41345

    Linda Andersson, BMA, 0046762756531, linda.mr.andersson@vgregion.se

    Georgios Tsikandylakis, MD, PhD

  • Hässleholm Hospital

    Hässleholm

    Maziar Mohaddes, MD, PhD

    Maziar Mohaddes, MD, PhD

  • Danderyd Hospital

    Stockholm

    Olof Sköldenberg, MD, PhD

    Olof Sköldenberg, MD, PhD

  • Akademiska University Hospital

    Uppsala

    Cyrus Brodén, MD, PhD, cyrus.broden@akademiska.se

    Cyrus Brodén, M, PhDD

Other trials in Sweden

Denmark1 site
  • Hvidovre Hospital

    Copenhagen

    Anders Troelsen, PhD, +45 38 62 67 74, Anders.Troelsen@regionh.dk

Other trials in Denmark

Norway1 site
  • Oslo University Hospital

    Oslo

    Stephan M Röhrl, PhD, +47 22 22 09 87, s.m.rohrl@medisin.uio.no

Other trials in Norway

About this study

Official title: The Accuracy of CT-based Implant Movement for the Evaluation of Cup and Stem Stability, When Plain Radiography is Not Conclusive for Loosening, in Patients Scheduled for Revision Hip Arthroplasty. A Multicenter Study

The goal of this validation study is to compare the preoperative implant stability, assessed by Implant Movement Analysis (IMA), provocation dual CT scans, with the intraoperative stability evaluation in revision hip arthoplasty. The main question it aims to answer is:

Does IMA reflect the intraoperative clinical evaluation of implant stability? Participants scheduled for revision hip arthoplasty will undergo IMA preoperativelly in addition to rutine clinical work up. During revision arthoplasty, a surgeon blinded to the IMA results will assess clinically the stability of the hip prosthesis. IMA will be compared with the intraoperative findings to assess IMAs sensitivity and specificity

Being tested
Implant motion provocation CT
Keywords
implant stabilty, THA, radiographic evaluation, IMA, Implant Movement Analysis, Revision THA
Medical subject headings
Prosthesis Failure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Implant motion provocation CTDiagnostic test

    Implant Movement Analysis. A low dose CT scan is performed with the hip fixed in external rotation. Then another low dose CT scan is performed with the hip fixed in internal rotation.The CT scans are then overimposed to each other and implant motion in relation to host bone is visualized,

Study groups in NCT06924567
Study groupRoleWhat they receive
Study groupPatients with painful THA, scheduled for reviision hip arthoplasty, with no signs of obvious implant loosening in either the cup or the stem.
Receives: Diagnostic Test: Implant motion provocation CT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cup and stem stability

    The stability of the cup and the stem is evaluated:

    1. Preoperatively with IMA as binary outcome (loose/not loose).
    2. Intraoperatively by the surgeon as binary outcome (loose/notloose).

    Measured: within 2 months month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Apr 2025
  2. Study start15 Sep 2026 (estimated)
  3. Primary completion31 Dec 2029 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
600 participants (estimated)
Target duration
2 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT06924567
Sponsor's protocol ID
284803
Acronym
MULTICIMA
Status last verified
Mar 2026
First submitted
5 Apr 2025
Last updated
12 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Publications

  • Olivecrona H, Olivecrona L, Weidenhielm L, Noz ME, Kardos J, Maguire GQ Jr, Zeleznik MP, Aspelin P. A new technique for diagnosis of acetabular cup loosening using computed tomography: preliminary experience in 10 patients. Acta Orthop. 2008 Jun;79(3):346-53. doi: 10.1080/17453670710015247.

    PubMed 18622838
  • Lovera D, Sandberg O, Mohaddes M, Gyllensten H. Cost-effectiveness of implant movement analysis in aseptic loosening after hip replacement: a health-economic model. Cost Eff Resour Alloc. 2023 Nov 20;21(1):88. doi: 10.1186/s12962-023-00498-w.

    PubMed 37986000
  • Sandberg O, Carlsson S, Harbom E, Cappelen V, Tholen S, Olivecrona H, Wretenberg P. Inducible displacement CT increases the diagnostic accuracy of aseptic loosening in primary total hip arthroplasty. Acta Orthop. 2022 Oct 31;93:831-836. doi: 10.2340/17453674.2022.5240.

    PubMed 36314542

Questions about this trial

What is this clinical trial studying?

An observational study of Loosening, Prosthesis and Hip Arthropathy, run by Georgios Tsikandylakis, MD PhD at 6 sites in 3 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 12 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in Sweden, Denmark, Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Linda Andersson, BMA (0762756531, linda.mr.andersson@vgregion.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cup and stem stability (time frame: within 2 months month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06924567, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in